Efficacy of Remimazolam Tosilate for General Anesthesia in Patients Undergoing Laparoscopic Cholecystectomy

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2300071256

Enrollment

Unknown

Registered

2023-05-09

Start date

2023-05-15

Completion date

Unknown

Last updated

2023-08-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gallbladder stones

Interventions

Propofol group:Propofol

Remimazolam Tosilate group:Remimazolam Tosilate

Eligibility

Sex/Gender

All

Age

18 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1. Aged between 18 and 60 years; 2. Anesthesia ASA grade I-II; 3. BMI 18-28 kg/m^2; 4. Elective laparoscopic cholecystectomy; 5. Informed consent signed by himself or his family.

Exclusion criteria

Exclusion criteria: 1. Respiratory or circulatory dysfunction. 2. Severe neuropsychiatric disorders. 3. Patients who are allergic to or have contraindications with benzodiazepines, opioids, propofol and its ingredients. 4. Patients with a history of opioid and psychotropic drug dependence.

Design outcomes

Primary

Measure	Time frame
induction time;extubation time;heart rate and blood pressure;bispectral index;	—

Secondary

Measure	Time frame
injection pain;intraoperative awareness;	—

Countries

China

Contacts

Public ContactLuo Zhuxin

The First People's Hospital of Zunyi

172505167@qq.com+86 150 8555 8127

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 7, 2026